18 and older, any sex, with Bone Loss or Implant Complication. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Changes in Peri-implant Marginal Bone Level Between Baseline (Implant Placement) and 1 Year Follow upPrimary· At baseline (implant placement) and 1 year follow up
Standardized digital periapical radiographs were taken at baseline (implant placement) and at the 1-year follow-up using the long-cone paralleling technique with a custom jig. Peri-implant marginal bone levels were measured on both the mesial and distal aspects to assess bone loss. Changes in peri-implant marginal bone levels were calculated by comparing the measurements at the 1-year follow-up to the baseline values.
Group
Value
95% CI
Control Group
0.80
± 0.92
Test Group
0.32
± 0.47
Changes in Keratinized Mucosa WidthSecondary· At baseline (implant placement) and 1 year follow up
The width of the keratinized mucosa was measured at the mid-buccal aspect of the abutments using a periodontal probe with 1.0 mm markings. Measurements were repeated at the 1-year follow-up at the same location and compared to the baseline values.
Group
Value
95% CI
Control Group
0.90
± 0.77
Test Group
0.42
± 0.42
Changes in Lingual Mucosa ThicknessSecondary· At baseline (implant placement) and 1 year follow up
The thickness of the lingual mucosa at each implant site was measured at the center of the implant site from the bone crest using a periodontal probe with 1.0 mm markings. Measurements were repeated at the 1-year follow-up at the same location and compared to the baseline values taken on the day of implant surgery.
Group
Value
95% CI
Control Group
0.71
± 0.59
Test Group
0.38
± 0.26
Implant Success Rate According to the 2017 Classification Criteria Set by the American Academy of Periodontology (AAP)Secondary· 12 months after surgical implantation
Success was determined by the implant's ability to meet these clinical factors, such as the absence of pain, infection, mobility, and radiographic bone loss beyond the acceptable threshold of the follow-up period, as assessed at 12 months post-surgical implantation.
Group
Value
95% CI
Control Group
0
Test Group
0
Sponsor's own description
The aim of this study was to evaluate the effects of definitive abutment connection at the time of implant placement on peri-implant bone levels and soft tissue changes in posterior maxilla and mandible regions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Loma Linda University
Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04043286.